Evidence map›Paper›PMID 36451051›Full record

ArticleBiochemical genetics2023

SOX2-Induced Linc-ROR Upregulation Inhibits Gastric Carcinoma Cell Proliferation and Metastasis Via the miR-580-3p/ANXA10 Pathway.

Liping Bai, Yifan Zhuang, Jun Xie, Kai Liu, Shengchang Yin, Feng Yan

Abstract read
PubMed Publisher
In one paragraph

Article in Biochemical genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Liping Bai *Department of Gastrointestinal Surgery, School of Medicine, Zhongshan Hospital of Xiamen University, No.201-209 Hubin South Road, Siming District, Xiamen, Fujian, China.
Yifan Zhuang *Department of Gastrointestinal Surgery, School of Medicine, Zhongshan Hospital of Xiamen University, No.201-209 Hubin South Road, Siming District, Xiamen, Fujian, China.
Jun XieDepartment of Gastrointestinal Surgery, School of Medicine, Zhongshan Hospital of Xiamen University, No.201-209 Hubin South Road, Siming District, Xiamen, Fujian, China.
Kai LiuDepartment of Gastrointestinal Surgery, School of Medicine, Zhongshan Hospital of Xiamen University, No.201-209 Hubin South Road, Siming District, Xiamen, Fujian, China.
Shengchang YinDepartment of Gastrointestinal Surgery, School of Medicine, Zhongshan Hospital of Xiamen University, No.201-209 Hubin South Road, Siming District, Xiamen, Fujian, China.
Feng YanDepartment of Gastrointestinal Surgery, School of Medicine, Zhongshan Hospital of Xiamen University, No.201-209 Hubin South Road, Siming District, Xiamen, Fujian, China. yanfeng@xmzsh.com.
Zhongshan Hospital of Xiamen University · CN

Funding

Xiamen Medical and Health Guidance Project 3502Z20209031
6 · The paper itself

Abstract

Previous studies have proven that long intergenic non-coding RNA regulator of reprogramming (Linc-ROR) plays opposing roles in different cancer types. This work intended to investigate its functions and underlying mechanisms in gastric carcinoma (GCa) progression. RT-qPCR was utilized for gene expression measurement. GCa cell viability, apoptosis, migration, and invasion were detected by functional assays, including CCK-8, flow cytometry, and Transwell assays. ChIP assay and Dual-luciferase reporter assay were utilized to affirm the associations between genes. Linc-ROR expression dramatically declined in GCa tissues and cell lines. Linc-ROR upregulation suppressed GCa cell proliferation, migration, and invasion but accelerated GCa cell apoptosis. As for Linc-ROR-associated molecular mechanisms in GCa, SOX2 associated with Linc-ROR promoter region to activate Linc-ROR transcription in GCa cells; Linc-ROR upregulated ANXA10 level in GCa cells by competitively binding to miR-580-3p. As revealed by rescue assays, Linc-ROR-induced inhibition on malignant biological behaviors of GCa cells could be partially abated by ANXA10 deletion or miR-580-3p upregulation. SOX2-activated Linc-ROR serves as a cancer suppressor to restrain GCa progression in vitro via the miR-580-3p/ANXA10 pathway, suggesting a promising diagnostic and therapeutic target for GCa patients.

Indexed as

CarcinomaMicroRNAsRNA, Long NoncodingStomach NeoplasmsAnnexinsCell Line, TumorCell ProliferationHumansSOXB1 Transcription FactorsUp-RegulationAnnexinsANXA10 protein, humanLinc-RNA-RoR, humanMicroRNAsMIRN580 microRNA, humanRNA, Long NoncodingSOX2 protein, humanSOXB1 Transcription FactorsANXA10Gastric carcinomaLinc-RORmiR-580-3pSOX2

Identifiers

PMID36451051
OpenAlexW4310471881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.